Published in Br J Cancer on October 04, 2004
Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas. J Clin Pathol (2006) 1.20
Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer. Virchows Arch (2006) 1.16
Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway. BMC Cancer (2010) 0.94
Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013: A Retrospective Study. Medicine (Baltimore) (2015) 0.88
Relative and disease-free survival for breast cancer in relation to subtype: a population-based study. J Cancer Res Clin Oncol (2013) 0.84
Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry. Breast Cancer Res Treat (2012) 0.84
Breast cancer survival in Germany: a population-based high resolution study from Saarland. PLoS One (2013) 0.78
The role of oestrogen and progesterone receptors in breast cancer - immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women. Contemp Oncol (Pozn) (2015) 0.75
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet (1998) 22.64
Regression models for relative survival. Stat Med (2004) 5.40
Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst (2004) 4.57
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer (2003) 3.89
Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics (1982) 3.18
A computer program package for relative survival analysis. Comput Programs Biomed (1985) 3.10
Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology (1992) 2.75
Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer (1994) 2.06
Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat (2002) 2.04
Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol (1999) 1.55
Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer (2001) 1.52
Differences in stage and therapy for breast cancer across Europe. Int J Cancer (2001) 1.51
Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer (1997) 1.46
Breast carcinoma survival in Europe and the United States. Cancer (2004) 1.43
Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med (2003) 1.36
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer. Am J Clin Pathol (1980) 1.25
Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria. Hum Pathol (1988) 1.16
Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. Eur J Cancer (1995) 1.03
Tubular carcinoma of the breast. Cancer (1978) 1.02
Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J Surg Oncol (1995) 1.01
Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences. Cancer (1989) 0.96
The importance of histologic type on breast cancer survival. J Clin Epidemiol (1997) 0.93
Prognosis in breast cancer: the effect of age and menstrual status. Clin Oncol (1979) 0.91
An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays. J Steroid Biochem Mol Biol (1996) 0.85
The standardization of estrogen receptors. J Steroid Biochem Mol Biol (1993) 0.81
CHARMM: the biomolecular simulation program. J Comput Chem (2009) 27.71
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med (1999) 8.01
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol (2000) 5.37
TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature (2001) 5.24
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol (2000) 5.01
Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet (1994) 4.38
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol (2001) 4.23
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol (2002) 3.91
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol (2003) 3.88
BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med (2001) 3.40
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med (2001) 3.18
Three key residues form a critical contact network in a protein folding transition state. Nature (2001) 3.09
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet (1989) 2.98
NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med (1994) 2.61
Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol (1998) 2.49
Small-world view of the amino acids that play a key role in protein folding. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 2.43
Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique (2003) 2.25
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer (1984) 2.07
A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med (1997) 2.05
Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.04
[Passive smoking: an environmental health risk]. Ned Tijdschr Geneeskd (2004) 2.04
High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg (2000) 2.03
MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesion. AJR Am J Roentgenol (1994) 2.03
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL). Ann Oncol (2012) 2.03
Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer (1998) 1.96
[The relationship between health gain and effort in mass screening for breast cancer]. Ned Tijdschr Geneeskd (1997) 1.95
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol (1997) 1.95
Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol (2002) 1.91
Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique (2008) 1.88
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity (1996) 1.87
Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (2000) 1.86
Validation of cancer prevalence data from a postal survey by comparison with cancer registry records. Am J Epidemiol (1994) 1.86
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer (2011) 1.84
Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health (1989) 1.81
A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000). Eur J Cancer (2007) 1.81
Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature (1992) 1.79
Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer (2003) 1.79
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med (1999) 1.77
Variation in survival of patients with lung cancer in Europe, 1985-1989. EUROCARE Working Group. Eur J Cancer (1998) 1.77
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Identification of novel loci affecting entry of Salmonella enteritidis into eukaryotic cells. J Bacteriol (1992) 1.76
Cancer prevalence in European registry areas. Ann Oncol (2002) 1.72
Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm Genome (1999) 1.71
A human killer inhibitory receptor specific for HLA-A1,2. J Immunol (1996) 1.70
Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer (1988) 1.69
[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault]. Prog Urol (2009) 1.67
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manage (1998) 1.64
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol (1999) 1.64
Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol (2004) 1.63
Toward a comparison of survival in American and European cancer patients. Cancer (2000) 1.63
Gastric cancer after positive screening faecal occult blood testing and negative assessment. Dig Liver Dis (2007) 1.62
Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol (1999) 1.62
The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.61
Variations in the survival of adult cancer patients in Italy. Tumori (1997) 1.60
Multi-state Markov models in cancer screening evaluation: a brief review and case study. Stat Methods Med Res (2010) 1.60
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J Clin Oncol (2000) 1.59
Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer (1998) 1.58
The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol (1997) 1.58
An asbestos hazard in the reprocessed textile industry. Am J Ind Med (1987) 1.56
Gender differences in stage-adjusted bladder cancer survival. Urology (2000) 1.55
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST) Eur J Cancer (1999) 1.55
Disability, psychosocial factors and mortality among the elderly in a rural French population. J Clin Epidemiol (1990) 1.55
Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci U S A (1990) 1.54
Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer (2012) 1.54
Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene (2012) 1.53
The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer (2001) 1.53
Does an organised screening programme reduce the inequalities in breast cancer survival? Ann Oncol (2011) 1.53
Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer (2000) 1.52
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma. Leuk Lymphoma (2007) 1.51
Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J Immunol (2001) 1.51
Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987. Eur J Cancer (1996) 1.50